News9th June 2026CellVoyant and Axol Bioscience partner to advance AI-guided imaging for cardiomyocyte manufacturing
News31st March 2026PRISM ALS: New stem cell models could transform research into treatments for MND/ALS
News4th March 2026Axol Bioscience joins quantum biotechnology consortium advancing Alzheimer’s research
News17th March 2025New MyoMaxTM Media Enhances iPSC-Derived Cardiomyocyte Maturity for Superior In Vitro Cardiac Models
News24th June 2025ALS TDI Announces New Agreement with Axol Bioscience to Expand Access to ALS Patient iPSC-Derived Cells for Global Research
News21st May 2025Large-Scale Manufacturing Options for Human IPSC-Derived Retinal Pigment Epithelium (RPE) Cells
News8th April 2025Custom Manufacturing of iPSC-Derived Microglia to Advance Neurodegeneration Disease Models
News28th March 2025Moving on from primary cells… The rise of iPSC-fueled in vitro models in dermatology and cosmetics
News26th March 2025New partnership looks to improve cell reprogramming methods for healthcare benefits
News14th March 2025Axol Bioscience and StrataStem Launch Novel iPSC Collection to Advance Alzheimer’s Disease Research
News17th February 2025A Deep Dive into Dry AMD Research using iPSCs: Interview with Florian Régent from Axol Bioscience
News13th February 2025Collaboration & Quality: Advancing Neuro Disease Models through Custom Manufacturing of iPSC-derived cells
